The Brigham Board Review in Endocrinology 2018 (Videos+PDFs)

The Brigham Board Review in Endocrinology 2019

Brigham and Women’s Hospital and Oakstone Board Review

Keep Up with Current Trends in Your Field

This CME course in endocrinology is extremely thorough, covering a range of key topics and core concepts in the specialty aiming to facilitate correct diagnosis and treatment of endocrine disorders. The Brigham Board Review in Endocrinology includes case-based lectures on topics like type 1 and type 2 diabetes, thyroid cancers, pituitary masses, polycystic ovarian syndrome, infertility and assisted reproduction, obesity management, etc. It will help you to better:

• Prepare for ABIM Endocrinology certification and recertification examinations
• Integrate and demonstrate increased overall knowledge of endocrine diseases
• Correlate pathophysiology and pathobiology with clinical presentations
• Evaluate the current therapeutic strategies with risks and potential benefits
• Attain the latest knowledge for managing diabetes, endocrine hypertension, hypothyroidism, etc.
• Apply knowledge attained to your daily practice, optimizing patient care and outcomes

Expand Your Skills

Available online or via audio MP3 CDs, The Brigham Board Review in Endocrinology provides a maximum of 32.75 AMA PRA Category 1 Credits ™ and 32.75 MOC points. Get access to unbiased, evidence-based content and case-based reviews so you can expand your knowledge and incorporate the latest guidelines into your daily practice.

Accreditation

Oakstone Publishing, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation

Oakstone Publishing, LLC designates this enduring material for a maximum of 32.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 32.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Date of Original Release: December 31, 2018

Credit Expiration Date: December 31, 2021

CME credit is obtained upon successful completion of a program post-test.

Learning Objectives

After viewing this activity, participants should be able to affirm or modify their approach to patient management in the following areas:

• Integrate and demonstrate increased overall knowledge of endocrine diseases
• Identify and improve knowledge and clinical competence-based practice gaps in endocrinology
• Correlate pathophysiology and pathobiologic principles with clinical presentations
• Describe optimal therapeutic strategies and their risks and benefits
• Apply the knowledge and strategies gained through participation in this activity to the board exam and daily practice

Intended Audience

This activity was designed for fellows/trainees and practicing endocrinologists and other professional affiliates (internists with an interest in endocrinology) who are preparing to become board certified, maintaining their certification, or who seek CME in attempt to improve patient care.

Topics/Speaker:

Diabetes Mellitus and Hypoglycemia: Overview of Diabetes

• Type 2 Diabetes: Overview, Screening and Diagnosis of Diabetes – Marie E. McDonnell, MD

• Diabetes Prevention: From Evidence to Clinical Recommendations – Vanita Aroda, MD

• Overview of Type 1 Diabetes – Margo S. Hudson, MD

Diabetes Mellitus and Hypoglycemia: Management of Hyperglycemia

• Lifestyle Modification in Diabetes Management – Vanita Aroda, MD

• Antidiabetic Agents 1: Metformin, Sulfonylureas, Meglitinides and Thiazolidinediones – Amir M. Tirosh, MD, PhD

• Antidiabetic Agents 2: DPP-4, GLP-1 and SGLT-2: New Approaches to Type 2 Diabetes – Margo S. Hudson, MD

• Antidiabetic Agents 3: Insulin – Alexander Turchin, MD

• Selecting Antidiabetic Therapy in Type 2 Diabetes – Marie E. McDonnell, MD

• Assessing Glycemic Control in Type 2 Diabetes – Alexander Turchin, MD

• Inpatient Hyperglycemia: Evidence-Based Approaches and Treatment Strategies – Nadine E. Palermo, DO

• Hyperglycemic Crisis: Diagnosis, Management and Transition of Care – Nadine E. Palermo, DO

• Diabetes in Pregnancy – Nadine E. Palermo, DO

Diabetes Mellitus and Hypoglycemia: Chronic Complications of Diabetes

• Microvascular and Dermatologic Complications of Diabetes – Margo S. Hudson, MD

Diabetes Mellitus and Hypoglycemia: Review

• Diabetes Cases for the Boards – Lee-Shing Chang, MD

Lipids, Obesity and Nutrition

• Update in Obesity Management – Florencia Halperin, MD

• Assessment and Treatment of Dyslipidemia – Jorge Plutzky, MD

Thyroid Disorders

• Hypothyroidism – Ellen Marqusee, MD

• Hyperthyroidism and Thyroiditis – Matthew I. Kim, MD

• Thyroid Nodules – Ellen Marqusee, MD

• Improving Thyroid Nodule Care with Molecular Diagnostics – Preoperative Assessment – Erik K. Alexander, MD

• Thyroid Cancers – Sana Ghaznavi MD, FRCPC

• Thyroid Cases for the Boards – Ole-Petter R. Hamnvik, MB, BCh, BAO, MMSc

Calcium and Bone Disorders

• Evaluation of the Patient with Low Bone Density – Meryl LeBoff ,MD

• Treatment of Osteoporosis – Sharon H. Chou, MD

• Hypercalcemia – J. Carl Pallais, MD

• Hypocalcemia – J. Carl Pallais, MD

• Topics in Metabolic Bone Disease – Eva S. Liu, MD

• Calcium and Bone Cases for the Boards – Carolyn B. Becker, MD

Pituitary and Hypothalamic Disorders

• Anterior and Posterior Pituitary Insufficiency – Le Min, MD, PhD

• Pituitary Masses – Ursula B. Kaiser, MD

• Prolactin and Growth Hormone Excess – Ana Paula De Abreu Silva Metzger MD, PhD

• Neuroendocrine Cases for the Boards – Ursula B. Kaiser, MD

Adrenal Disorders

• Primary and Secondary Adrenal Insufficiency – Jonathan S. Williams, MD, MMSc

• Diagnosis and Treatment of Cushing’s Syndrome – Gail K. Adler, MD, PhD

• Primary Hypertension – Naomi D. Fisher, MD

• Endocrine Hypertension – Naomi D. Fisher, MD

• Adrenal Tumors and Cancer – Anand Vaidya, MD, MMSc

• Update on Pheochromocytomas and Paragangliomas – Anand Vaidya, MD, MMSc

• Adrenal Cases for the Boards – Anand Vaidya, MD, MMSc

Reproductive Endocrinology

• Evaluation of the Patient with Menstrual Irregularities – Maria A. Yialamas, MD

• Management of Menopausal Symptoms – Ole-Petter R. Hamnvik, MB, BCh, BAO, MMSc

• Contraception Overview and use in Women with Endocrine Disease – Caryn R. Dutton, MD

• Polycystic Ovarian Syndrome and Approach to Female Androgen Excess Disorders – Grace Huang, MD

• Infertility and Assisted Reproduction – Janis H. Fox, MD

• Complexities in the Diagnosis and Treatment of Androgen Deficiency Syndromes in Men – Shalender Bhasin, MB, BS

• Evaluation and Management of Erectile Dysfunction – Michael P. O’Leary, MD

• Reproductive Endocrinology Cases for the Boards – Anna L. Goldman, MD

Other Topics

• Hereditary Syndromes in Endocrinology: Genetics and Management – Adi Barlev-Ehrenberg, MD, MS

• Hormonal Treatment of Gender Non-Conforming Individuals – Ole-Petter R. Hamnvik, MB, BCh, BAO, MMSc

• Hypoglycemia in Non-Diabetic Patients: Diagnosis and Management – Sylvia Oh Kehlenbrink, MD

• Endocrine Disorders in Pregnancy – Ellen Wells Seely, MD

Additional Content

• Cardiovascular Risk Reduction in Diabetes – Bindu Chamarthi, MD, MMSc

Product Details